HCM
SYNH

Highline Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Highline Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-626,400
Closed -$27.3M – 46
2017
Q4 		$27.3M Buy
+626,400
New +$29.3M 0.9% 29

Other funds holding SYNH

THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highline Capital Management's SYNH Position: Q1 2018 in Review

Highline Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2018, closing a stake of 626,400 shares — an estimated $27.3M sold.

Highline Capital Management first reported a position in SYNH in Q4 2017 and held it in 1 quarter. The position peaked at $27.3M in Q4 2017. 218 funds tracked by Wall St. Rank hold SYNH as of Q1 2018.

  • Highline Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2018 after selling out during the quarter.
  • Highline Capital Management sold 626,400 Syneos Health, Inc. Class A Common Stock shares in Q1 2018, an estimated $27.3M.
  • Highline Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2017 and held it in 1 quarter.
  • Highline Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $27.3M in Q4 2017.
  • 218 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2018.

Based on Highline Capital Management's 13F filing for Q1 2018, filed 15 May 2018.